Related Experiment Video
Updated: Jun 17, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
HLA-B27: what's new?
1Department of Rheumatology, City Care Centre, Thorpe Road, Peterborough PE3 6DB, UK. nick.sheehan@pbh-tr.nhs.uk
Abstract:
The HLA-B27 molecule is one of the most fascinating in medicine. Its contribution to the aetiopathogenesis of SpA and other diseases, and its protective action in certain infections, continue to challenge our understanding of its immunobiology and physiological roles. Animal studies have helped to cast light on ways in which HLA-B27 exerts its effects. Subtle variations in structure and behaviour between B27 subtypes that are strongly associated with SpA, compared with those whose association is neutral or weak, are helping to elucidate its pathogenetic mechanisms. However, none of the current hypotheses fully explains the observed actions of HLA-B27. Consequently, attention is turning to how haplotype linkages and genetic networks involving other MHC and non-MHC genes influence the penetrance and clinical expression of B27. HLA-B27 gives an intriguing insight into the connection between heredity and disease. As well as its close links with SpA, various other associations have been reported between B27 and diseases of different organs and systems. Evidence is also accumulating that it mitigates the virulence of HIV and other viral infections. The role of HLA-B27 as an aid to diagnosis, prognosis and disease management is gradually becoming clearer.
Insights
The Human Leukocyte Antigen B27 (HLA-B27) molecule is linked to Spondyloarthritis (SpA) and influences viral infections. Research explores its complex immunobiology, genetic associations, and clinical relevance in disease.
Area of Science:
- Immunology
- Genetics
- Medicine
Background:
- The Human Leukocyte Antigen B27 (HLA-B27) molecule plays a critical role in immune responses.
- Its association with Spondyloarthritis (SpA) and other diseases, alongside protective effects against infections, highlights its complex immunobiology.
- Understanding HLA-B27's functions is crucial for unraveling disease pathogenesis and host defense mechanisms.
Purpose of the Study:
- To explore the multifaceted roles of HLA-B27 in disease aetiopathogenesis and host defense.
- To investigate the influence of HLA-B27 subtypes and genetic variations on disease expression.
- To clarify the diagnostic, prognostic, and therapeutic implications of HLA-B27.
Main Methods:
- Review of existing literature and animal studies on HLA-B27.
- Analysis of structural and behavioral variations among HLA-B27 subtypes.
- Investigation of genetic networks involving MHC and non-MHC genes influencing HLA-B27.
Main Results:
- Subtle structural and behavioral differences in HLA-B27 subtypes correlate with SpA association.
- Current hypotheses do not fully explain all observed actions of HLA-B27.
- Evidence suggests HLA-B27 mitigates virulence in HIV and other viral infections.
Conclusions:
- HLA-B27 offers insights into the interplay between heredity and disease.
- Further research into genetic networks and haplotype linkages is needed to fully understand HLA-B27's clinical expression.
- The role of HLA-B27 in disease diagnosis, prognosis, and management is becoming increasingly evident.
